P1443: AUTOLOGOUS NK CELLS AS CONSOLIDATION AFTER FRONT-LINE STEM CELL TRANSPLANTATION IN MULTIPLE MYELOMA: A LONG-TERM FOLLOW-UP

Bibliographic Details
Published in:	HemaSphere
Main Authors:	J. Lund, H. Nahi, S. Meinke, P.-H. Holmqvist, H.-G. Ljunggren, J. Aschan, E. Alici
Format:	Article
Language:	English
Published:	Wiley 2022-06-01
Online Access:	http://journals.lww.com/10.1097/01.HS9.0000848628.24223.c8

Similar Items

Consolidation and maintenance therapy with bortezomib for Vietnamese patients with multiple myeloma after autologous transplantation✰
by: Minh Phuong Vu, et al.
Published: (2023-01-01)

Autologous Hematopoietic Cell Transplant as an Effective Treatment Modality for Systemic Sclerosis and Multiple Myeloma
by: Memon H, et al.
Published: (2025-01-01)

Autologous Stem Cell Transplantation for Myeloma: Cytoreduction or an Immunotherapy?
by: Simone A. Minnie, et al.
Published: (2021-03-01)

Multiple Myeloma Patients at Various Cytogenetic Risks Benefit Differently from Autologous Stem Cell Transplantation as a Consolidation Therapy
by: Tianmei Zeng, et al.
Published: (2015-01-01)

Role of NK Cells in Progression and Treatment of Multiple Myeloma
by: Iman Chanchiri, et al.
Published: (2025-04-01)

Melphalan dose intensity for autologous stem cell transplantation in multiple myeloma
by: Samer A. Srour, et al.
Published: (2021-08-01)

Maintenance Strategies Post-Autologous Stem Cell Transplantation for Newly Diagnosed Multiple Myeloma
by: Sarah A. Bird, et al.
Published: (2020-05-01)

Lenalidomide before and after Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma
by: S. A. Tuchman, et al.
Published: (2012-01-01)

Dynamics of NK cell subsets following autologous hematopoietic stem cell transplantation in adult oncologic patients
by: Gabirel Astarloa-Pando, et al.
Published: (2025-10-01)

UPDATE ON THE ROLE OF AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION IN MULTIPLE MYELOMA
by: Patrizia Tosi, et al.
Published: (2012-01-01)

Post-Autologous (ASCT) Stem Cell Transplant Therapy in Multiple Myeloma
by: Zeina Al-Mansour, et al.
Published: (2014-01-01)

UPDATE ON THE ROLE OF AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION IN MULTIPLE MYELOMA
by: Patrizia Tosi, et al.
Published: (2012-11-01)

The Progress of Autologous Hematopoietic Stem Cell Transplantation in the Treatment of Multiple Myeloma
by: Ya-Nan Wang MS, et al.
Published: (2025-03-01)

Multiple Myeloma: The Role of Autologous Stem Cell Transplantation in the Era of Immunotherapy
by: Serena Rocchi, et al.
Published: (2024-05-01)

AUTOLOGOUS STEM CELL TRANSPLANTATION IN MULTIPLE MYELOMA: IS IT STILL THE RIGHT CHOICE?
by: Patrizia Tosi
Published: (2014-07-01)

Patient‐reported outcomes following autologous stem cell transplant for patients with multiple myeloma
by: Noa Biran, et al.
Published: (2021-08-01)

Hodgkin’s Lymphoma after Autologous Stem-Cell Transplantation: Effective Consolidation with Brentuximab Vedotin
by: Adrian Schmidt
Published: (2020-11-01)

Autologous hematopoietic stem cell transplantation for multiple myeloma in the age of CAR T cell therapy
by: Charlotte F. M. Hughes, et al.
Published: (2024-03-01)

The Role of Ferritin and Folate in Determining Stem Cell Collection for Autologous Stem Cell Transplant in Multiple Myeloma
by: Charles J. Weeks, et al.
Published: (2025-01-01)

Autologous, allogeneic hematopoietic cell transplantation and CAR-T/NK therapy: what is their real importance in PTCL?
by: Samuel C. F. Couto, et al.
Published: (2023-08-01)

Subcutaneous bortezomib incorporated into the bortezomib-thalidomide-dexamethasone regimen as part of front-line therapy in the context of autologous stem cell transplantation for multiple myeloma
by: Anne Lok, et al.
Published: (2014-03-01)

Retrospective Analysis of Patients with Multiple Myeloma Post Autologous Stem Cell Transplant
by: Disha SATYA, et al.
Published: (2025-09-01)

Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma in the Era of New Drugs
by: OV Pirogova, et al.
Published: (2018-04-01)

Certain Aspects of Autologous Hematopoietic Stem Cell Transplantation in Patients with Multiple Myeloma
by: SV Gritsaev, et al.
Published: (2017-01-01)

Autologous stem cell transplantation in the treatment of multiple myeloma single center experience
by: Marjanović Slobodan, et al.
Published: (2011-01-01)

Autologous Stem Cell Transplantation in Multiple Myeloma with Renal Failure: Friend or Foe?
by: Hongfei Zhong, et al.
Published: (2019-01-01)

Experience of Autologous Stem Cell Transplant in Multiple Myeloma: The Patient and Caregiver Perspective
by: Doris K Hansen MD, et al.
Published: (2023-09-01)

Comparison of single and double autologous stem cell transplantation in multiple myeloma patients
by: Malkan Umit Yavuz, et al.
Published: (2021-01-01)

Multiple myeloma patients with a long remission after autologous hematopoietic stem cell transplantation
by: Oren Pasvolsky, et al.
Published: (2024-05-01)

The correlation between T regulatory cells and autologous peripheral blood stem cell transplantation in multiple myeloma
by: Ayşe Pınar Erçetin, et al.
Published: (2011-06-01)

The correlation between T regulatory cells and autologous peripheral blood stem cell transplantation in multiple myeloma
by: Ayşe Pınar Erçetin, et al.
Published: (2011-05-01)

Regulatory T-cell depletion in the setting of autologous stem cell transplantation for multiple myeloma: pilot study
by: Justin Kline, et al.
Published: (2020-05-01)

Role and Modulation of NK Cells in Multiple Myeloma
by: Marie Thérèse Rubio, et al.
Published: (2021-04-01)

Minimal residual disease following autologous stem cell transplant in myeloma: impact on outcome is independent of induction regimen
by: Ruth M. de Tute, et al.
Published: (2016-02-01)

Changes in Laboratory Indexes for Multiple Myeloma Patients Before and After Autologous Stem Cell Transplant
by: Zhao R, et al.
Published: (2023-12-01)

Efficacy and outcome of autologous transplantation in rare myelomas
by: Curly Morris, et al.
Published: (2010-12-01)

Autologous stem cell transplantation in multiple myeloma: Post-transplant outcomes of Taiwan Blood and Marrow Transplantation Registry
by: Tzu-Chuan Huang, et al.
Published: (2019-01-01)

Tandem autologous/allogeneic hematopoietic cell transplantation with bortezomib maintenance therapy for high-risk myeloma
by: Damian J. Green, et al.
Published: (2017-11-01)

P923: TANDEM AUTOLOGOUS STEM CELL TRANSPLANTATIONS STILL BENEFIT FOR MYELOMA PATIENTS: A POOLING META-ANALYSIS
by: C.-H. Lee, et al.
Published: (2022-06-01)

In vivo expansion of a CD9+ decidual-like NK cell subset following autologous hematopoietic stem cell transplantation
by: Ane Orrantia, et al.
Published: (2022-10-01)